New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Abstract
Idiopathic granulomatous mastitis (IGM) is a disfiguring inflammatory breast disease without effective treatment. We report the largest IGM cohort treated with methotrexate monotherapy.Chart review was performed on patients evaluated by the Rheumatology Clinic, with histopathologically-established IGM, treated with methotrexate, and at least one follow up appointment.Nineteen female patients with an mean age of 33.5 years were identified. Most failed treatment with antibiotics, prednisone, and surgical intervention. By 15 months of treatment with methotrexate, 94% had disease improvement and 75% achieved disease remission.Methotrexate monotherapy is an effective treatment for IGM.
View details for DOI 10.3899/jrheum.181205
View details for PubMedID 31203215